| Ryan Bradford Thompson, PA | |
|
7733 East Jefferson, Detroit, MI 48213 | |
| (313) 499-4900 | |
| Not Available |
| Full Name | Ryan Bradford Thompson |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant - Medical |
| Location | 7733 East Jefferson, Detroit, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043544125 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 5601005559 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Bradford Thompson, PA 17197 N. Laurel Park Drive, Suite 161, Livonia, MI 48152 Ph: (734) 338-8300 | Ryan Bradford Thompson, PA 7733 East Jefferson, Detroit, MI 48213 Ph: (313) 499-4900 |
News Archive
Athletes in combat sports often try to shed body weight in order to compete against lighter and smaller opponents. A new doctoral thesis from the University of Gothenburg, Sweden, points to the human body's limited ability to quickly recover following extensive short-term weight loss.
Normal, healthy heart muscle is well-supplied with oxygen-rich blood. But UT Southwestern Medical Center cardiologists have been able to regenerate heart muscle by placing mice in an extremely low-oxygen environment.
In December 2019, a new viral infection was detected in Wuhan, China. On January 30, 2020, the World Health Organization declared the outbreak a public health emergency of international concern, and on March 11, the COVID-19 pandemic.
Upsher-Smith Laboratories, Inc. today announced the successful completion of its global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using the company's proprietary formulation technology.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that the China Food and Drug Administration (CFDA) has approved the Company's application to conduct a Phase 2 global clinical trial in ovarian clear cell carcinoma (OCCC) patients for its proprietary drug candidate ENMD-2076.
› Verified 4 days ago
Ms. Lilia Popadiuk, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 6071 W Outer Dr, Detroit, MI 48235 Phone: 313-993-0200 | |
Mrs. Rachelle Noel Wright, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Sybrena Evans, Physician Assistant Medicare: Medicare Enrolled Practice Location: 3901 Beaubien St, Detroit, MI 48201 Phone: 313-833-4490 | |
Mrs. Kimberly Louise Powell, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 6071 W Outer Dr, Detroit, MI 48235 Phone: 313-966-6870 | |
Tiffany Drane, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 22101 Moross Rd, Detroit, MI 48236 Phone: 313-343-4000 | |
Basma J Alobahi, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 6100 Dorothy St, Detroit, MI 48211 Phone: 313-921-5881 | |
Amy G. Connolly, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 20400 W Warren Ave, Detroit, MI 48228 Phone: 313-271-0500 Fax: 313-271-9313 |